Profile
Mr. Constantine Chinoporos is on the Board of Directors at Geron Corp.
and Halozyme Hypercon, Inc. Mr. Chinoporos was previously employed as a Chief Operating & Business Officer by Applied Therapeutics, Inc., a Chief Business Officer by Albireo Pharma, Inc., a Chief Business Officer by Boston Pharmaceuticals, Inc., and a Head-Corporate Development by Genzyme Corp.
He received his undergraduate degree from Cornell University and an MBA from Johnson Graduate School of Management.
Constantine Chinoporos active positions
| Companies | Position | Start |
|---|---|---|
| GERON CORPORATION | Director/Board Member | 2026-03-24 |
Elektrofi, Inc.
Elektrofi, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company with a breakthrough ultra-high concentration microparticle technology for biologics | Director/Board Member | - |
Former positions of Constantine Chinoporos
| Companies | Position | End |
|---|---|---|
| APPLIED THERAPEUTICS, INC. | Chief Operating Officer | 2026-02-02 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 2023-02-28 |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Corporate Officer/Principal | 2021-09-30 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Training of Constantine Chinoporos
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Commercial Services |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Applied Therapeutics, Inc.
Applied Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative drugs and technologies for debilitating diseases | Health Technology |
Elektrofi, Inc.
Elektrofi, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company with a breakthrough ultra-high concentration microparticle technology for biologics | Commercial Services |
- Stock Market
- Insiders
- Constantine Chinoporos
















